SCHEMBL1038352

SCHEMBL1038352

O=c1[nH]cc(Br)cc1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL620683 0.75
SCHEMBL1542620 0.75
SCHEMBL4257130 0.75
SCHEMBL1853196 0.75
SCHEMBL1887803 0.75
SCHEMBL4154284 0.75
SCHEMBL590523 0.75
SCHEMBL17546137 0.72 ERCC1 (0.52)
SCHEMBL1857404 0.70 ERCC1 (0.50)
SCHEMBL4725368 0.70 DYRK1A (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4574828-A2 PROCESS FOR PREPARING BTK INHIBITORS F. Hoffmann-La Roche AG (CH) 2025-06-25 EP disclosed
US-20240425481-A1 SUBSTITUTED BENZIMIDAZOLES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS EPIGENETIX, INC. 2024-12-26 US disclosed
US-11981657-B2 Substituted benzimidazoles, their preparation and their use as pharmaceuticals EPIGENETIX, INC. (US) 2024-05-14 US disclosed
US-20230357179-A1 RAF KINASE INHIBITORS AND METHODS OF USE THEREOF DECIPHERA PHARMACEUTICALS, LLC 2023-11-09 US disclosed
US-20230348471-A1 BRUTON'S TYROSINE KINASE INHIBITOR AND PREPARATION METHOD THEREFOR ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. (CN) 2023-11-02 US disclosed
US-20230348471-A1 BRUTON'S TYROSINE KINASE INHIBITOR AND PREPARATION METHOD THEREFOR ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. (CN) 2023-11-02 US disclosed
US-20230250103-A1 PROCESS FOR PREPARING BTK INHIBITORS GENENTECH, INC. (US) 2023-08-10 US disclosed
US-20230250103-A1 PROCESS FOR PREPARING BTK INHIBITORS GENENTECH, INC. (US) 2023-08-10 US disclosed
US-20230250103-A1 PROCESS FOR PREPARING BTK INHIBITORS GENENTECH, INC. (US) 2023-08-10 US disclosed
US-11661424-B2 Process for preparing BTK inhibitors GENENTECH, INC. (US) 2023-05-30 US disclosed
WO-2008033858-A2 KINASE INHIBITORS, AND METHODS OF USING AND IDENTIFYING KINASE INHIBITORS CGI PHARMACEUTICALS, INC. (US) 2008-03-20 WO disclosed
WO-2008033854-A1 CERTAIN SUBSTITUTED AMIDES, METHOD OF MAKING, AND METHOD OF USE THEREOF CGI PHARMACEUTICALS, INC. (US) 2008-03-20 WO disclosed
WO-2008033857-A2 SUBSTITUTED AMIDES, METHOD OF MAKING, AND METHOD OF USE THEREOF CGI PHARMACEUTICALS, INC. (US) 2008-03-20 WO disclosed
EP-1863766-A2 CERTAIN SUBSTITUTED AMIDES, METHOD OF MAKING, AND METHOD OF USE THEREOF CGI Pharmaceuticals, Inc. (US) 2007-12-12 EP disclosed
US-20060229337-A1 Certain substituted amides, method of making, and method of use thereof GILEAD CONNECTICUT, INC. 2006-10-12 US disclosed
WO-2006099075-A2 CERTAIN SUBSTITUTED AMIDES, METHOD OF MAKING, AND METHOD OF USE THEREOF CGI PHARMACEUTICALS, INC. (US) 2006-09-21 WO disclosed
US-20040186104-A1 Novel pyridinone and related heterocyclic derivatives ASTRAZENECA AB (SE) 2004-09-23 US disclosed
EP-1387829-A1 NOVEL PYRIDINONE AND RELATED HETEROCYCLIC DERIVATIVES AstraZeneca AB (SE) 2004-02-11 EP disclosed
WO-2002090333-A1 NOVEL PYRIDINONE AND RELATED HETEROCYCLIC DERIVATIVES ASTRAZENECA AB (SE) 2002-11-14 WO disclosed
US-4008086-A PYRIDONE OR PYRIDAZONE DERIVATIVES KONISHIROKU PHOTO INDUSTRY CO., LTD. (JA) 1977-02-15 US disclosed